MESCHIARI, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.133
EU - Europa 7.110
AS - Asia 7.064
SA - Sud America 1.074
AF - Africa 191
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 7
Totale 26.605
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.759
IT - Italia 2.995
SG - Singapore 2.157
CN - Cina 1.622
GB - Regno Unito 1.186
VN - Vietnam 841
HK - Hong Kong 767
BR - Brasile 746
DE - Germania 529
SE - Svezia 509
BD - Bangladesh 443
RU - Federazione Russa 362
FI - Finlandia 349
FR - Francia 308
KR - Corea 235
CA - Canada 233
NL - Olanda 221
ID - Indonesia 188
IN - India 180
AR - Argentina 113
TR - Turchia 97
BG - Bulgaria 83
MX - Messico 76
ES - Italia 75
UA - Ucraina 66
LT - Lituania 65
JP - Giappone 64
ZA - Sudafrica 63
PL - Polonia 58
IQ - Iraq 57
CO - Colombia 54
IR - Iran 53
CL - Cile 45
EC - Ecuador 44
AE - Emirati Arabi Uniti 42
PK - Pakistan 41
IE - Irlanda 40
MY - Malesia 37
AT - Austria 35
CZ - Repubblica Ceca 34
SI - Slovenia 33
MA - Marocco 30
BE - Belgio 27
TH - Thailandia 27
AU - Australia 25
CH - Svizzera 22
SA - Arabia Saudita 22
JO - Giordania 21
PH - Filippine 21
VE - Venezuela 21
UZ - Uzbekistan 19
NP - Nepal 16
RO - Romania 16
EG - Egitto 15
KZ - Kazakistan 15
PE - Perù 15
PY - Paraguay 15
IL - Israele 14
TN - Tunisia 14
GR - Grecia 13
CR - Costa Rica 12
DO - Repubblica Dominicana 12
BO - Bolivia 11
KE - Kenya 11
TW - Taiwan 11
DZ - Algeria 10
AZ - Azerbaigian 9
JM - Giamaica 9
PS - Palestinian Territory 9
AL - Albania 8
HU - Ungheria 8
LV - Lettonia 8
NO - Norvegia 8
SN - Senegal 8
UY - Uruguay 8
BH - Bahrain 7
GE - Georgia 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
DK - Danimarca 6
NG - Nigeria 6
PA - Panama 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
ET - Etiopia 5
MD - Moldavia 5
CI - Costa d'Avorio 4
CY - Cipro 4
EE - Estonia 4
MK - Macedonia 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BB - Barbados 3
BF - Burkina Faso 3
BZ - Belize 3
CG - Congo 3
EU - Europa 3
GA - Gabon 3
Totale 26.532
Salva come PNG Salva come JPEG
Città #
Ashburn 1.512
Singapore 1.373
Santa Clara 1.316
Fairfield 779
Hong Kong 743
Southend 653
San Jose 646
Chandler 638
Hefei 535
Nyköping 333
Council Bluffs 330
Woodbridge 303
Houston 294
Cambridge 291
London 282
New York 282
Los Angeles 280
Ho Chi Minh City 275
Seattle 274
Helsinki 268
Beijing 256
Seoul 226
Wilmington 212
Milan 210
Dallas 195
Modena 195
Rome 193
Bologna 186
Hanoi 184
Munich 165
Chicago 160
Jakarta 150
San Diego 138
The Dalles 117
Ann Arbor 114
Lauterbourg 100
Shanghai 95
Moscow 91
Buffalo 87
Princeton 76
Toronto 74
São Paulo 71
Sofia 70
Frankfurt am Main 67
Naples 61
Parma 59
Boardman 56
Bremen 55
Amsterdam 54
Orem 53
Tokyo 50
Warsaw 47
Jacksonville 46
Turku 46
Da Nang 45
Atlanta 43
Dearborn 43
Montreal 42
Hillsboro 41
Paris 38
North York 37
Palermo 37
Redwood City 36
Reggio Emilia 36
Salt Lake City 36
Turin 36
Fremont 33
Phoenix 33
Florence 31
Johannesburg 31
Stockholm 31
Nuremberg 30
Brooklyn 29
Dublin 29
Catania 28
Kent 28
Mumbai 28
Redondo Beach 28
Chennai 27
Denver 27
Rio de Janeiro 27
Haiphong 26
Mexico City 26
Bari 25
Poplar 25
Madrid 24
Santiago 24
Verona 24
Columbus 23
Lappeenranta 23
Brussels 22
Portsmouth 22
Rimini 22
Belo Horizonte 21
Des Moines 21
Grafing 21
Guangzhou 21
Izmir 21
Biên Hòa 20
Dong Ket 20
Totale 16.707
Salva come PNG Salva come JPEG
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 802
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 682
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 555
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 516
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 471
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 456
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 452
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 438
Metabolic reprograming shapes neutrophil functions in severe COVID-19 411
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 406
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 394
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 377
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 374
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 369
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 367
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 362
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 361
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 361
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 347
Ectopic fat is linked to prior cardiovascular events in men with HIV. 344
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 337
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature 329
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination 326
Hypokalemia in Patients with COVID-19 325
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 313
Peritoneal dialysis in the time of coronavirus disease 2019 303
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 292
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 287
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 283
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 281
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 270
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 269
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 263
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 262
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 257
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 255
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 253
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 251
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 251
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 250
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 247
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 246
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 240
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 240
Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection 238
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 236
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program 236
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 233
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 232
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 231
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 229
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 229
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 224
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 220
Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab 213
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 213
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 213
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 210
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 210
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: a practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases 207
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 207
Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (Xdr) and multidrug-resistant (mdr) pseudomonas aeruginosa: Resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs 206
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 204
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 199
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 199
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 197
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 197
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 194
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 193
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 189
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 188
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 187
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. 186
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 180
The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae 176
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 170
Fusobacterium necrophorum septic arthritis of the hip: a case-report and literature review 169
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 167
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 164
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 164
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) 163
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study) 163
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 162
Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci 162
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 158
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 158
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 156
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 156
A time-series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 Epidemics: a multicenter cross-national ecological study on behalf of QUARANTINE (QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics) study project 154
Continued decay of HIV proviral DNA upon vaccination with HIV-1 Tat of subjects on long-term ART: An 8-year follow-up study 149
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 141
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 141
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 135
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 133
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience 131
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 131
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 127
Streptococcus equi Subspecies zooepidemicus Endocarditis and Meningitis in a 62-Year-Old Horse Rider Patient: A Case Report and Literature Review 121
Reduction trend of mcr-1 circulation in Emilia-Romagna Region, Italy 116
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia 115
Totale 25.657
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.409
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 0 0 0 0 0 0 193
2021/20222.228 149 141 167 69 114 148 266 122 232 160 406 254
2022/20232.405 272 293 195 215 238 272 74 203 278 71 140 154
2023/20242.281 89 135 163 194 374 222 174 256 104 105 181 284
2024/20255.528 198 120 133 389 909 874 444 328 610 312 551 660
2025/202611.249 822 503 897 1.225 1.407 589 1.338 592 1.117 1.149 926 684
Totale 26.866